Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Taskinen

Showing results (221-230 of 318) with videos related to

Pageof 32
Sort By:
Diabetes|July 1, 1996
Multiple lipoprotein abnormalities in type I diabetic patients with renal diseaseP H Groop, T Elliott, A Ekstrand, et al.
Atherosclerosis|March 21, 1997
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal womenM Tilly-Kiesi, J Kahri, T Pyörälä, et al.
Metabolism: Clinical and Experimental|February 1, 1989
Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal menF Contaldo, E D'Arrigo, V Carandente, et al.
Diabetologia|March 1, 1995
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDMC M Forsblom, J G Eriksson, A V Ekstrand, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
The 13th annual meeting of the European Lipoprotein ClubL P Aggerbeck, L M Havekes, S Humphries, et al.
Journal of Lipid Research|July 31, 1998
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activitiesN Mero, A Van Tol, L M Scheek, et al.
Journal of Internal Medicine|May 8, 2021
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetesF Jansson Sigfrids, E H Dahlström, C Forsblom, et al.
Atherosclerosis|April 9, 2025
Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humansC J Packard, M R Taskinen, E Björnson, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patientsT Kuusi, M S Nieminen, C Ehnholm, et al.
Diabetes|April 30, 2003
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patientsF Pellmé, U Smith, T Funahashi, et al.
Pageof 32

Showing results (221-230 of 318) with videos related to

Sort By:
Pageof 32
Diabetes|July 1, 1996
Multiple lipoprotein abnormalities in type I diabetic patients with renal diseaseP H Groop, T Elliott, A Ekstrand, et al.
Atherosclerosis|March 21, 1997
Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal womenM Tilly-Kiesi, J Kahri, T Pyörälä, et al.
Metabolism: Clinical and Experimental|February 1, 1989
Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal menF Contaldo, E D'Arrigo, V Carandente, et al.
Diabetologia|March 1, 1995
Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDMC M Forsblom, J G Eriksson, A V Ekstrand, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1991
The 13th annual meeting of the European Lipoprotein ClubL P Aggerbeck, L M Havekes, S Humphries, et al.
Journal of Lipid Research|July 31, 1998
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activitiesN Mero, A Van Tol, L M Scheek, et al.
Journal of Internal Medicine|May 8, 2021
Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetesF Jansson Sigfrids, E H Dahlström, C Forsblom, et al.
Atherosclerosis|April 9, 2025
Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humansC J Packard, M R Taskinen, E Björnson, et al.
Arteriosclerosis (Dallas, Tex.)|March 1, 1989
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patientsT Kuusi, M S Nieminen, C Ehnholm, et al.
Diabetes|April 30, 2003
Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patientsF Pellmé, U Smith, T Funahashi, et al.
Pageof 32